-+ 0.00%
-+ 0.00%
-+ 0.00%

Benchmark Maintains Buy on Quipt Home Medical, Lowers Price Target to $4

Benzinga·05/14/2025 13:50:22
Listen to the news
Benchmark analyst Bill Sutherland maintains Quipt Home Medical (NASDAQ:QIPT) with a Buy and lowers the price target from $6 to $4.